Avant and IMC Execute BLK MKT™ Trademark Licensing Agreement for the German Medical Cannabis Market
TORONTO, GLIL YAM, Israel and KELOWNA, BC., April 4, 2024 /PRNewswire/ — IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the “Company“, “IMCannabis“, or “IMC“), a leading medical cannabis company with operations in Israel and Germany, and Avant Brands Inc. (TSX:AVNT) (OTCQX: AVTBF) (FRA: 1BU0) (“Avant“) a leading producer of innovative cannabis products, jointly announce the signing of an international trademark licensing agreement (the “Licensing Agreement“) granting Adjupharm GmbH, IMC’s German subsidiary (“Adjupharm” or “IMC Germany“, as applicable), the exclusive right to launch the BLK MKT™ brand in the German medical cannabis market. The Licensing Agreement constitutes another major milestone with respect to the relationship between the two cannabis companies.
Related news for (AVTBF)
- Avant Brands Closes $3.9 Million Offering of Unsecured Convertible Debenture Units
- Avant Brands Announces $3.9 Million Private Placement of Unsecured Convertible Debenture Units
- Avant Brands Reports Continued Growth in Q2 2024 Financial Results
- Avant Brands Announces Closing of Non-Brokered Private Placement
- Avant Brands Inc. Announces Voting Results From 2024 Annual General Meeting of Shareholders